<!DOCTYPE html>
<html lang="en">
<head>
     <meta charset="UTF-8">
     <meta name="viewport" content="width=device-width, initial-scale=1.0">
     <title>Cartagena Protocol on Biosafety to the Convention on Biological Diversity</title><link href="navigation.css" rel="stylesheet" type="text/css"/> <link href="document.css" rel="stylesheet" type="text/css"/>  <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
     <!-- Compiled and minified CSS -->
     <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/materialize/1.0.0/css/materialize.min.css"></head><body>     <img class="responsive-img" style="display: inline-block;" src="../../images/FINAL LOGO.png" width="32px" alt="GS IAS Logo"> <ul class="center notranslate" style="display: inline-block;"> 
          <li id="home" class="col s2"><a  href="../../index.html"><i  class="small orange-text material-icons">home</i></a></li>
          <li id="backL" class="col s2 "><a  href="javascript:goBack()"><i id="back" class="small orange-text material-icons">arrow_back</i>
               <span style="font-family: fantasy; font-size: small;">back</span></a></li> <li id="forwardL" class="col s2 "><a  href="javascript:goForward()">
               <span style="font-family:fantasy; font-size: small;">fwd</span><i id="forward" class="small orange-text material-icons">arrow_forward</i></a>
          </li>
          <li id="answerSpeak" class="col s2"><a  href="javascript:answerSpeak()"><i id="answerSpeakI" class="small orange-text material-icons">play_circle_filled</i></a></li>
          <li class="col s2"><a href="javascript:resumeSpeak()"><i id="pause-resume" class="small pink-text material-icons noDisplay">pause</i></a></li>  
          </ul><p class="top_nav"  ><a href="part1063.htm">&lt; Previous</a><span> | </span><a href="../index.html">Contents</a><span> | </span><a href="part1065.htm">Next &gt;</a></p> <div class="item main"  > <h3 style="padding-left: 6pt;text-indent: 0pt;text-align: left;">Cartagena Protocol on Biosafety to the Convention on Biological Diversity</h3><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">Biosafety refers to the need to protect human health and the environment from the possible adverse effects of the products of modern biotechnology.</p><p style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">The Convention clearly recognizes these twin aspects of modern biotechnology.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 36pt;text-indent: 0pt;text-align: left;">1. Access to and transfer of technologies</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 36pt;text-indent: 0pt;text-align: left;">2. Appropriate procedures to enhance the safety of biotechnology technologies.</p><p style="text-indent: 0pt;text-align: left;"><br/></p>  <p  style="padding-left: 6pt;text-indent: 0pt;text-align: left;">Objective </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">Is to contribute to ensuring an adequate level of protection in the field of the safe transfer, handling and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health, and specifically focusing on transboundary movements.</p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Cartagena Protocol on Biosafety is an additional agreement to the Convention on Biological Diversity.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Protocol establishes procedures for regulating the import and export of LMOs from one country to another.</span></p><p class="s1" style="padding-top: 3pt;padding-left: 36pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Protocol also requires Parties to ensure that LMOs being shipped from one country to another are handled, packaged and transported in a safe manner.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The shipments must be accompanied by documentation that clearly identifies the LMOs, specifies any requirements for the safe handling, storage, transport and use and provides contact details for further information.</span></p><p style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;    text-align: left;">There are two main sets of procedures, one for LMOs intended for direct introduction into the environment, known as the advance informed agreement (AIA) procedure, and another for LMOs intended for direct use as food or feed, or for processing (LMOs-FFP).</p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Advance Informed Agreement </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Under the AIA procedure, a country intending to export an LMO for intentional release into the environment must notify in writing the Party of import before the first proposed export takes place.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Party of import must acknowledge receipt of the notification within 90 days and must communicate its decision on whether or not to import the LMO within 270 days.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Parties are required to ensure that their decisions are based on a risk assessment of the LMO, which must be carried out in a scientifically sound and transparent manner.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Once a Party takes a decision on the LMO, it is required to communicate the decision as well as a summary of the risk assessment to a central information system, the Biosafety Clearing-House (BCH).</span></p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">LMOs- food or feed, or for processing </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Under the procedure for LMOs-FFP, Parties that decide to approve and place such LMOs on the market are required to make their decision and relevant information, including the risk assessment reports, publicly available through the BCH.</span></p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Nagoya—Kuala Lumpur Supplementary Protocol </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Cartagena Protocol is reinforced by the Nagoya— Kuala Lumpur Supplementary Protocol on Liability and Redress.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Supplementary Protocol specifies response measures to be taken in the event of damage to biodiversity resulting from LMOs.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: justify;">⧫  <span class="p">The competent authority in a Party to the Supplementary Protocol must require the person in control of the LMO (operator) to take the response measures or it may implement such measures itself and recover any costs incurred from the operator.</span></p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Nagoya Protocol </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization (ABS) to the Convention on Biological Diversity is a supplementary agreement to the Convention on Biological Diversity.</p><p style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">It provides a transparent legal framework for the effective implementation of one of the three objectives of the</p><p style="padding-top: 3pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">CBD.</p><p style="text-indent: 0pt;text-align: left;"><br/></p>  <p  style="padding-left: 6pt;text-indent: 0pt;text-align: left;">Objective </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">Is the fair and equitable sharing of benefits arising from the utilization of genetic resources, thereby contributing to the conservation and sustainable use of biodiversity.</p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Obligations </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">The Nagoya Protocol sets out core obligations for its contracting Parties to take measures in relation to access to genetic resources, benefit-sharing and compliance.</p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Access obligations </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Domestic-level access measures are to:</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Create legal certainty, clarity and transparency</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Provide fair and non-arbitrary rules and procedures</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Establish clear rules and procedures for prior informed consent and mutually agreed terms</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Provide for issuance of a permit or equivalent when access is granted</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Create conditions to promote and encourage research contributing to biodiversity conservation and sustainable use</span></p><p class="s1" style="padding-top: 11pt;padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Pay due regard to cases of present or imminent emergencies that threaten human, animal or plant health</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Consider the importance of genetic resources for food and agriculture for food security</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p>  <p  style="padding-left: 6pt;text-indent: 0pt;text-align: left;">Benefit-sharing obligations </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Domestic-level benefit-sharing measures are to provide for the fair and equitable sharing of benefits arising from the utilization of genetic resources with the contracting party providing genetic resources.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Utilization includes research and development on the genetic or biochemical composition of genetic resources, as well as subsequent applications and commercialization.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Sharing is subject to mutually agreed terms.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Benefits may be monetary or non-monetary such as royalties and the sharing of research results.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p>  <p  style="padding-left: 6pt;text-indent: 0pt;text-align: left;">Compliance obligations </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">Specific obligations to support compliance with the domestic legislation or regulatory requirements of the contracting party providing genetic resources, and contractual obligations reflected in mutually agreed terms, are a significant innovation of the Nagoya Protocol. Contracting Parties are to:</p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Take measures providing that genetic resources utilized within their jurisdiction have been accessed in accordance with prior informed consent, and that mutually agreed terms have been established, as required by another contracting party</span></p><p class="s1" style="padding-top: 4pt;padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Cooperate in cases of alleged violation of another contracting party’s requirements</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Encourage contractual provisions on dispute resolution in mutually agreed terms</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Ensure an opportunity is available to seek recourse under their legal systems when disputes arise from mutually agreed terms</span></p><p class="s1" style="padding-top: 11pt;padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Take measures regarding access to justice</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Take measures to monitor the utilization of genetic resources after they leave a country including by designating effective checkpoints at any stage of the value-chain: research, development, innovation, pre- commercializa-tion or commercialization</span></p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Traditional knowledge </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Nagoya Protocol addresses traditional knowledge associated with genetic resources with provisions on access, benefit-sharing and compliance.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">It also addresses genetic resources where indigenous and local communities have the established right to grant access to them.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Contracting Parties are to take measures to ensure these communities’ prior informed consent, and fair and equitable benefit-sharing, keeping in mind community laws and procedures as well as customary use and exchange.</span></p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Importance </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 6pt;text-indent: 0pt;    text-align: left;">The Nagoya Protocol will create greater legal certainty and transparency for both providers and users of genetic resources by:</p><p class="s1" style="padding-top: 11pt;padding-left: 36pt;text-indent: 0pt;text-align: left;">⧫  <span class="p">Establishing more predictable conditions for access to genetic resources.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Helping to ensure benefit-sharing when genetic resources leave the contracting party providing the genetic resources</span></p><p style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;    text-align: left;">By helping to ensure benefit-sharing, the Nagoya Protocol creates incentives to conserve and sustainably use genetic resources, and therefore enhances the contribution of biodiversity to development and human well-being.</p>  <p  style="padding-top: 11pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">The Biodiversity Target </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">It was adopted in May 2002 during the sixth Conference of the Parties to the Convention on Biological Diversity.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The Target aimed to achieve, by 2010 ‘a significant reduction of the current rate of biodiversity loss at the global, regional and national level as a contribution to poverty alleviation and to the benefit of all life on earth’.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">Unfortunately, we were unable to meet the target. As we are facing an ever-increasing biodiversity crisis, we need a new, clear and realistic target to respond to it.</span></p>  <p  style="padding-top: 3pt;padding-left: 6pt;text-indent: 0pt;text-align: left;">Strategic Plan For Biodiversity 2011-2020 </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s1" style="padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">In the tenth meeting of the Conference of the Parties, held in 2010, in Nagoya, Aichi Prefecture, Japan, adopted a revised and updated Strategic Plan for Biodiversity, including the Aichi Biodiversity Targets, for the 20112020 period.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: left;">⧫  <span class="p">The tenth meeting of the Conference of the Parties agreed to translate this overarching international framework into national biodiversity strategies and action plans within two years.</span></p><p class="s1" style="padding-top: 11pt;padding-left: 35pt;text-indent: 0pt;    text-align: justify;">⧫  <span class="p">Additionally, the meeting decided that the fifth national reports, due by 31 March 2014, should focus on the implementation of the 2011-2020 Strategic Plan and progress achieved towards the Aichi Biodiversity Targets.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="nav">&nbsp;&nbsp;</p><p class="nav">&nbsp; </p></div><p class="nav"><a href="part1063.htm">&lt; Previous</a><span> | </span><a href="../index.html">Contents</a><span> | </span><a href="part1065.htm">Next &gt;</a></p><p class="nav">&nbsp;&nbsp;</p><div id="google_translate_element"></div><script src="index.js"></script>
<script type="text/javascript" src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/materialize/1.0.0/js/materialize.min.js"></script></body></html>
